ClinicalTrials.gg
Sign In

Biological

Genetically Engineered Hematopoietic Stem Progenitor Cells clinical trials

studies test it
3
open now
1
in phase 3
0
first study started
2012

Keep track of what changes. Save the Genetically Engineered Hematopoietic Stem Progenitor Cells studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Genetically Engineered HSPCs
3
Genetically Engineered Hematopoietic Stem Progenitor Cells
2

Studies by the year they started

3 studies that test it; most in 2012 (1)

Studies that test Genetically Engineered Hematopoietic Stem Progenitor Cells, by start year
YearStudies
20121
20161
20211

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it.

Hodgkin Disease
1

Who runs them

Industry 0 · Other 3

Hospital Infantil Universitario Niño Jesús, Madrid, Spain (1) · City of Hope Medical Center (1) · Fred Hutchinson Cancer Center (1)

Often tested with

Tested in the same studies.

Filgrastim (2) · Plerixafor (2) · Basiliximab (1) · Carmustine (1) · Cytarabine (1) · Etoposide (1) · Recombinant Granulocyte Colony-Stimulating Factor (1) · Yttrium Y 90 Basiliximab (1)

Studies

Open first, then newest update. How each study uses Genetically Engineered Hematopoietic Stem Progenitor Cells is read from its arms, and is right about nine times in ten.

Testing it · 3